Fig. 2From: Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patientsPie charts of NSCLC patients with KRAS mutations. Pie charts showing the proportions of KRAS mutation and wildtype tumors in the mCohort (left), and the proportions of different KRAS mutation subtypes in the mCohort (right) which included patients from the iCohortBack to article page